Base editing generates substantial off-target single nucleotide variants

Genome editing tools including CRISPR/Cas9 and base editors hold great promise for correcting pathogenic mutations. Unbiased genome-wide off-target effects of the editing in mammalian cells is required before clinical applications, but determination of the extent of off-target effects has been difficult due to the existence of single nucleotide polymorphisms (SNPs) in individuals. Here, we developed a method named GOTI (Genome-wide Off-target analysis by Two-cell embryo Injection) to detect off-target mutations without interference of SNPs. We applied GOTI to both the CRISPR-Cas9 and base editing (BE3) systems by editing one blastomere of the two-cell mouse embryo and then compared whole genome sequences of progeny-cell populations at E14.5 stage. Sequence analysis of edited and non-edited cell progenies showed that undesired off-target single nucleotide variants (SNVs) are rare (average 10.5) in CRISPR-edited mouse embryos, with a frequency close to the spontaneous mutation rate. By contrast, BE3 editing induced over 20-fold higher SNVs (average 283), raising the concern of using base-editing approaches for biomedical application.

[1]  Steve D. M. Brown,et al.  Response to "unexpected mutations after CRISPR-Cas9 editing in vivo" , 2018 .

[2]  Steve D. M. Brown,et al.  Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo” , 2018, Nature Methods.

[3]  J. Drake,et al.  Rates of spontaneous mutation. , 1998, Genetics.

[4]  Thomas M. Keane,et al.  Off-target mutations are rare in Cas9-modified mice , 2015, Nature Methods.

[5]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[6]  L. Hennighausen,et al.  Mutation frequency is not increased in CRISPR–Cas9-edited mice , 2018, Nature Methods.

[7]  N. Navaratnam,et al.  RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA. , 2000, Biochimica et biophysica acta.

[8]  David R. Liu,et al.  Publisher Correction: Base editing: precision chemistry on the genome and transcriptome of living cells , 2018, Nature Reviews Genetics.

[9]  O. Rando,et al.  Nucleosome positioning: how is it established, and why does it matter? , 2010, Developmental biology.

[10]  Lothar Hennighausen,et al.  CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome , 2017, Nature Communications.

[11]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[12]  Ewa A. Bergmann,et al.  Indel variant analysis of short-read sequencing data with Scalpel , 2015, Nature Protocols.

[13]  J. Doudna,et al.  Cornerstones of CRISPR–Cas in drug discovery and therapy , 2016, Nature Reviews Drug Discovery.

[14]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[15]  Tao Liu,et al.  Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse , 2016, Nucleic Acids Res..

[16]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[17]  Jonathan Y. Hsu,et al.  Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo” , 2018, Nature Methods.

[18]  Jin-Soo Kim,et al.  Towards therapeutic base editing , 2018, Nature Medicine.

[19]  J. Joung,et al.  Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases , 2016, Nature Reviews Genetics.

[20]  Guoliang Xu,et al.  CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development , 2017, Cell Research.

[21]  Michel Sadelain,et al.  Gene therapy comes of age , 2018, Science.

[22]  J. Kent,et al.  Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR , 2016, Genome Biology.

[23]  Jin-Soo Kim,et al.  Therapeutic applications of CRISPR RNA-guided genome editing. , 2017, Briefings in functional genomics.

[24]  A. Bradley,et al.  Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements , 2018, Nature Biotechnology.

[25]  David R. Liu,et al.  Base editing: precision chemistry on the genome and transcriptome of living cells , 2018, Nature Reviews Genetics.

[26]  Jin-Soo Kim,et al.  Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases , 2014, Bioinform..

[27]  A. Bassuk,et al.  Unexpected mutations after CRISPR–Cas9 editing in vivo , 2017, Nature Methods.

[28]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[29]  Eva Szomolanyi-Tsuda,et al.  The AIM2 inflammasome is essential for host-defense against cytosolic bacteria and DNA viruses , 2010, Nature Immunology.

[30]  K. Musunuru.  The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review , 2017, JAMA cardiology.

[31]  Richard L. Frock,et al.  Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases , 2014, Nature Biotechnology.

[32]  J. Joung,et al.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets , 2017, Nature Methods.

[33]  C. Burant,et al.  Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.

[34]  A. Krieg.  AIMing 2 defend against intracellular pathogens , 2010, Nature Immunology.

[35]  Claudio Mussolino,et al.  Refining strategies to translate genome editing to the clinic , 2017, Nature Medicine.

[36]  Dana Carroll,et al.  Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo , 2018, Proceedings of the National Academy of Sciences.

[37]  D. Schemske,et al.  OUTCROSSING RATE AND INBREEDING DEPRESSION IN TWO ANNUAL MONOECIOUS HERBS, BEGONIA HIRSUTA AND B. SEMIOVATA , 1993, Evolution; international journal of organic evolution.

[38]  A. Wilm,et al.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.

[39]  E. Kudryashova,et al.  Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component. , 2009, Human molecular genetics.

[40]  Hui Yang,et al.  One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs , 2017, Cell Research.

[41]  Martin J. Aryee,et al.  In vivo CRISPR editing with no detectable genome-wide off-target mutations , 2018, Nature.

[42]  M. Buck,et al.  Chromatin accessibility: a window into the genome , 2014, Epigenetics & Chromatin.